Cardiff Oncology

$0.00 (0.00%) As of 1:24 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.

About CRDF

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.

CEO
Mark Erlander
Employees
23
Headquarters
San Diego, California
Founded
1999

CRDF Key Statistics

Market cap
60.63M
Price-Earnings ratio
—
Dividend yield
—
Average volume
662.76K
High today
$1.41
Low today
$1.35
Open price
$1.35
Volume
438.68K
52 Week high
$8.92
52 Week low
$1.13

CRDF Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.23 per share
Actual
-$0.25 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure